Schroeder, H.A. : Pathogenesis of hypertension. Am. J. Med., 10: 189-209, 1951.
2.
Hatch, F.T.: Effects of withdrawal and restoration of dietary sodium chloride upon urinary electrolytes in patients with hypertension. Metabolism , 3: 160, 1954.
3.
Schroeder, H.A. : Management of arterial hypertension. Am. J. Med., 17: 540, 1954.
4.
Goldring, W., AND Chasis, H.: Hypertension and Hypertensive Disease. Commonwealth Fund , London, 1944.
5.
Moyer, J.H., Hughes, W., AND Huggins, R.: Cardiovascular and renal hemodynamic response to the administration of reserpine (Serpasil). Am. J. M. Sc., 227: 640, 1954 .
6.
Hughes, W., Dennis, E., Mcconn, R., Ford, R., AND Moyer, J.H.: Reserpine (serpasil) in the treatment of hypertension. Am. J. M. Sc., 228: 21, 1954.
7.
Cronheim, G. , Stripp, C., AND Brown, W.: Hypotensive agents from Rauwolfia serpentina, reserpine, and other alkaloids. Presented before Am. Soc. for Exper. Therap. &Pharmacol., Sept. 7, 1953, New Haven, Conn.
8.
Schlittler, E., AND Mcphillamy , H.B.: Chemistry of Rauwolfia alkaloids, including reserpine. Presented beforeNew York Academy of Sciences, Feb. 5, 1954 , New York.
9.
Finnerty, F.A. , JR.: The value of Rauwolfia serpentina in the hypertensive patient. Am. J. Med., 17: 629, 1954.
10.
Wilkins, R.W. : Rauwolfia in the treatment of essential hypertension . Am. J. Med., 17: 703, 1954.
11.
Mills, L.C. , AND Moyer, J.H.: The acute effects of hexamethonium on renal hemodynamics in normotensive and hypertensive human subjects. Am. J. M. Sc., 226: 1, 1953.
12.
Freis, E.D. : Recent developments in the treatment of hypertension. M. Clin. NorthAmerica, pp. 363-74, March, 1954.
13.
Nickerson, M., AND Goodman, L.S.: Pharmacological properties of new adrenergic blocking agent, n,n-dibenzyl-beta-chloroethylamine (dibenamine) . J. Pharmacol. & Exper. Therapy., 89: 167, 1947.
14.
O'Leary, J.F. : Cardiovascular actions of 1,4-bis(1,4-benzodioxan-2-yl-methyl) piperazine (McN-181,Dibozane), a new adrenergic blocking agent. Fed. Proc., 12: 355, 1953.
15.
Wilkins, R.W. : Veratrum viride and essential hypertension . New England J. Med., 242: 535, 1950.
16.
Rosenblatt, W.H., Haymond, T.A., Bellet , S., AND Koelle, G.B.: The effect of single intravenous and oral doses of McN-181 [1,4-bis (1,4-benzodioxan-2-ylmethyl) piperazine] upon the blood pressure of hypertensive subjects. Am. J. M. Sc., 227: 179, 1954.
17.
Kleh, J., AND Fazekas, J.F.: The use of apresoline in the hypertensive arteriosclerotic syndrome . Am. J. M. Sc., 227: 57, 1954.
18.
Smithwick, R.H. : Hypertension. A Symposium. p. 429. Univ. of Minn. Press, Minneapolis, 1951.
19.
Hammarström, S., AND Bechgaard, P.: Prognosis in arterial hypertension. Comparison between 251 patients after sympathectomy and selected series of 435 non-operated patients. Am. J. Med., 8: 53, 1950.
20.
Schaffer, A.J. , AND Markowitz, M.: Hypertension treated by nephrectomy: A report of 4 additional cases and a re-evaluation of prognosis and criteria for operation . Am. J. M. Sc., 227: 417, 1954 .
21.
Albert, S.N. , AND Coakley, C.S.: The use of chlorpromazine to control postanesthetic vomiting. Current Res. Anesth. & Analgesia, 33: 285, 1954.
22.
Laborit, H.: Sur 1' emploi des ganglioplégique en obstétricale. Press méd. , 60: 140, 1952.
23.
Hamon, J., Paraire, J., AND Velluz, J.: Remarques sur l'action du 4560 R.P. sur l'agitation maniaque. Ann. méd. psychol., 110: 331-335, 1952.
24.
Seneque, J., Roux, M., AND Huguenard, P.: Reflexions à propos de 47 cas d'anesthésie avec hypotension contrôlée . Mém. Acad. chir., 78: 333, 1952.
25.
Fournel, J.: Action du chlorhydrate de (dimethylamino-3' propyl)-10-chloro-3-phénothiazine (4,560 R.P.) sur le choc hémorragique expérimental du chien. Compt. rend Soc. biol., 146: 561-564, 1952.
26.
Forster, E., Forster, S., AND Maier, A.Suites neurologiques après arrat cardiaque de 15 minutes Semaine h6p . Paris, 28: 1547-1549, 1952 .
27.
Pellerat, M.J. : Un nouveau medicament sédatif et antiprurigineux . Lyon méd., 188: 270, 1953.
28.
David, M., Benda, P., AND Klein, F.: Traitement de l'etat de mal épileptique par la chlorpromazine. Bull. Soc. méd. Hôp. Paris, 69: 691-697, 1953.
29.
Vialard, C. : Note sur l'utilisation du largactil (4560 R.P.) comme potentialisateur de medicaments analgésiques chez les cancéreux douloureux résistants aux opiaces. Anesthésie, 10: 216-224, 1953.
30.
Editorial: Antiemetic drugs in therapy. New England J. Med., 249: 952, 1953.
31.
Kammerer, T. , AND Ebtinger, R.: First results of treatment of delirium tremens with chlorpromazine. Ann. méd. psychol., 112: 1-1, 102, 1954.
32.
Cummins, J.F. , AND Friends, D.G.: Use of chlorpromazine in chronic alcoholics . Am. J. M. Sc., 227: 561-564, 1954.
33.
Albert, S.N. , Rea, E.L., Duverney, C.A., Shea , J., AND Fazekas, J.F.: Use of chlorpromazine in the treatment of acute alcoholism. M. Ann. District of Columbia, 23: 245-247, 1954.
34.
Robinson, K.C. , AND Zuck, D.: Letter to Editor. Lancet , 2: 1349, 1954.
35.
Decourt, P. , Brunaud, M., AND Brunaud, S.Étude expérimentale de la prétendue action ganglioplégique de la chlorpromazine. Compt. rend. Soc. biol. , 147: 1602-1605, 1953 .
36.
Doshay, L.J. : Thorazine in paralysis agitans. J. A. M. A., 156: 680-684, 1954.
37.
Geiger, H., AND Finkelstein, B.A. : Largactil in der behandlung der Tuberkulose . Schweiz. med. Wchnschr., 84: 1063-64, 1954.
38.
Therapeutic report. Smith, Kline & French Laboratories, Philadelphia, Jan., 1955.
39.
Melville, K.I. : Observations on the adrenergic-blocking and antifibrillatory actions of chlorpromazine. Fed. Proc., 13: 386-389, 1954.
40.
Schneider, R.A., et al.: The pharmacodynamics of postural hypotension. (Abst.) Annual National meeting., Am. Fed. Clin. Res., Atlantic City, N. J., P. 69, May 1954.
41.
Rea, E.L., Shea, J., AND Fazekas, J.F.: Hypotensive action of chlorpromazine. J. A. M. A. , 156: 1249-1250, 1954.
42.
Moyer, J.H. , Kent, B., Knight , R., Morris, G., Huggins, R., AND Handley, C.H.: Laboratory and clinical observations on chlorpromazine (SKF-2601-A); hemodynamic and toxicological studies. Am. J. M. Sc., 227: 283, 1954 .
43.
Wilkins, R.W. : Combination of drugs in treatment of essential hypertension. Mississippi Doctor, 30: 359, 1953.
44.
Hafkenschiel, J.H., Friedland, C.K.: The effects of 1-hydrazinophthalazine on cerebral blood flow, vascular resistance, oxygen uptake, and jugular oxygen tension in hypertensive subjects. J. Clin. Invest., 32: 655, 1953.
45.
Stunkard, A.J. , Eurman, G.H., Wachspress , M., AND Wertheim, A.R.: Treatment of hypertensive disease with hydralazine; comparison of its action with that of low sodium diet in hospitalized patients. Am. J. Med., 17: 712, 1954.
46.
Schroeder, H.A.: Review of hypertension. J. Lab. & Clin. Med., 38: 949, 1951.
47.
Schroeder, H.A. , AND Morrow, J.D.: The control of arterial hypertension by hyphex, with an evaluation of other methods of therapy. M. Clin. NorthAmerica, 37: 991, 1953.
48.
Schroeder, H.A. , Morrow, J.D., AND Perry, H.M., JR.: Studies on the control of hypertension by hyphex. Circulation, 8: 672, 1953.
49.
Ford, R.V., AND Moyer, J.H.: Preliminary observations of Rauwiloid-hexamethonium combined therapy of hypertension . Am. Heart J., 46: 754, 1953.
50.
Finnerty, F.A. , JR., AND Fuchs, G.J. JR.: The veratrum treatment of toxemia of pregnancy. Am. J. Obst. & Gynec., 66: 830-841, 1953.
51.
Goldblatt, H. : Renal origin of hypertension. Physiol. Rev., 27: 120, 1947.
52.
Longcope, W.T. , AND Winkenwerder , W.L.: Clinical features of the contracted kidney due to pyelonephritis. Bull. Johns Hopkins Hosp., 53: 255, 1933.
53.
Kempner, W. : Treatment of hypertension with rice diet. Am. J. Med., 4: 545-577, 1948.
54.
Nelson, W.: Mitchell-Nelson Textbook of Pediatrics. W. B. Saunders Co., Philadelphia, 1951.